North America Animal Parasiticides Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA ANIMAL PARASITICIDES MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 DBMR MARKET POSITION GRID

2.7 VENDOR SHARE ANALYSIS

2.8 MULTIVARIATE MODELING

2.9 PRODUCT TYPE TIMELINE CURVE

2.1 MARKET APPLICATION COVERAGE GRID

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PORTER’S FIVE FORCES ANALYSIS

4.1.1 THREAT OF NEW ENTRANTS

4.1.2 BARGAINING POWER OF SUPPLIERS

4.1.3 BARGAINING POWER OF BUYERS

4.1.4 THREAT OF SUBSTITUTE PRODUCTS

4.1.5 INDUSTRY RIVALRY

4.2 PESTEL ANALYSIS

4.2.1 INTRODUCTION

4.2.2 POLITICAL FACTORS

4.2.2.1 ANIMAL DISEASE CONTROL POLICIES

4.2.2.2 GOVERNMENT LIVESTOCK HEALTH PROGRAMS

4.2.2.3 ZOONOTIC DISEASE PREVENTION INITIATIVES

4.2.3 ECONOMIC FACTORS

4.2.4 RISING VETERINARY HEALTHCARE COSTS

4.2.4.1 LIVESTOCK PRODUCTIVITY INVESTMENTS

4.2.4.2 DEMAND FOR AFFORDABLE TREATMENTS

4.2.4.3 EXPANSION OF ANIMAL HEALTHCARE SPENDING

4.2.4.4 GENERIC PARASITICIDE ADOPTION

4.2.5 SOCIAL FACTORS

4.2.5.1 GROWING ANIMAL HEALTH AWARENESS

4.2.5.2 PREVENTIVE PARASITE MANAGEMENT PRACTICES

4.2.5.3 RISING PET OWNERSHIP TRENDS

4.2.5.4 ANIMAL WELFARE CONCERNS

4.2.5.5 DEMAND FOR BETTER VETERINARY CARE

4.2.6 TECHNOLOGICAL FACTORS

4.2.6.1 ADVANCED PARASITICIDE FORMULATIONS

4.2.6.2 NOVEL DRUG DELIVERY SYSTEMS

4.2.6.3 DIGITAL VETERINARY PLATFORMS

4.2.6.4 IMPROVED PARASITE DIAGNOSTICS

4.2.6.5 RESEARCH ON NEW MOLECULES

4.2.7 ENVIRONMENTAL FACTORS

4.2.7.1 PARASITICIDE RESIDUE CONCERNS

4.2.7.2 VETERINARY WASTE MANAGEMENT

4.2.7.3 SUSTAINABLE MANUFACTURING PRACTICES

4.2.7.4 ECO-FRIENDLY PACKAGING ADOPTION

4.2.7.5 RESISTANCE MANAGEMENT INITIATIVES

4.2.8 LEGAL FACTORS

4.2.8.1 VETERINARY DRUG APPROVAL STANDARDS

4.2.8.2 SAFETY AND EFFICACY REGULATIONS

4.2.8.3 RESIDUE LIMIT COMPLIANCE

4.2.8.4 ANIMAL MEDICINE GUIDELINES

4.2.8.5 NORTH AMERICA REGULATORY HARMONIZATION

4.2.9 CONCLUSION

4.3 PATENT ANALYSIS

4.3.1 PATENT NUMBER AND EXPIRY

4.3.2 COUNTRY-LEVEL APPROVAL

4.3.3 LIST OF PRODUCTS REACHING EXPIRY IN NEXT 3 YEARS

4.3.4 PRODUCTS PATENTED IN SPECIFIC COUNTRIES

4.3.5 CONCLUSION

4.4 INDUSTRY INSIGHTS

4.5 PIPELINE ANALYSIS

4.5.1 CLINICAL TRIALS AND PHASE ANALYSIS

4.5.2 PRODUCT PIPELINE FOR ANIMAL PARASITICIDES

4.5.3 TARGET ANIMAL SAFETY STUDIES (TASS)

4.5.4 TARGET ANIMAL EFFECTIVENESS STUDIES (TAES)

4.6 R & D ANALYSIS

4.7 EPIDEMIOLOGY

4.7.1 INTRODUCTION

4.7.2 INCIDENCE OF INFESTATION BY REGION

4.7.3 TREATMENT ADOPTION RATE

4.7.4 PARASITE-RELATED MORTALITY RATE

4.7.5 COMPLIANCE AND THERAPY SWITCH MODEL

4.7.6 TREATMENT SUCCESS RATES

4.7.7 CONCLUSION

4.8 MARKETED PRODUCT ANALYSIS

4.8.1 INTRODUCTION

4.8.2 PRODUCT

4.8.2.1 BRAND NAME

4.8.2.2 GENERIC NAME

4.8.3 THERAPEUTIC INDICATION

4.8.4 PHARMACOLOGICAL CLASSIFICATION

4.8.5 PRIMARY INDICATION

4.8.6 MARKET STATUS

4.8.7 MEDICATION TYPE

4.8.8 PRODUCT DOSAGE FORM

4.8.9 DOSAGE AVAILABILITY

4.8.10 PACKAGING TYPE

4.8.11 ROUTE OF ADMINISTRATION

4.8.12 DOSING FREQUENCY

4.8.13 PRODUCT INSIGHT

4.8.14 OVERVIEW OF PRODUCT DEVELOPMENT (REGULATORY MILESTONES, SAFETY, EFFICACY, MARKET EXCLUSIVITY DATA)

4.8.14.1 FORECAST MARKET OUTLOOK

4.8.14.2 CROSS COMPETITION

4.8.14.3 PRODUCT PORTFOLIO

4.8.14.4 URRENT DEVELOPMENT SCENARIO

4.8.15 CONCLUSION

4.9 MARKET ACCESS

4.9.1 INTRODUCTION

4.9.2 10-YEAR MARKET FORECAST

4.9.3 CLINICAL TRIAL RECENT UPDATES

4.9.4 ANNUAL NEW APPROVED PRODUCTS

4.9.5 MAJOR MANUFACTURERS AND PARTNERSHIPS

4.9.6 MAJOR PRODUCT UPTAKE

4.9.7 CURRENT TREATMENT PRACTICES

4.9.8 IMPACT OF UPCOMING THERAPY TRENDS

4.9.9 CONCLUSION

5 HEALTHCARE TARIFFS IMPACT ANALYSIS

5.1 OVERVIEW

5.2 TARIFF STRUCTURES

5.2.1 NORTH AMERICA VS. REGIONAL TARIFF STRUCTURES

5.2.1.1 NORTH AMERICA

5.2.1.2 EUROPE

5.2.1.3 ASIA-PACIFIC

5.2.1.4 LATIN AMERICA

5.2.1.5 MIDDLE EAST AND AFRICA

5.2.2 UNITED STATES: USDA AND FDA TARIFF POLICIES, CMS PRICING MODELS

5.2.3 EUROPEAN UNION: CROSS-BORDER TARIFF REGULATIONS, REIMBURSEMENT POLICIES

5.2.4 ASIA-PACIFIC: GOVERNMENT-IMPOSED TARIFFS ON IMPORTED VETERINARY PRODUCTS

5.2.5 EMERGING MARKETS: CHALLENGES IN TARIFF IMPLEMENTATION

5.3 PHARMACEUTICAL TARIFFS AND TRADE BARRIERS

5.3.1 IMPORT DUTIES ON VETERINARY DRUGS VS. GENERICS

5.3.2 IMPACT ON PRODUCT AFFORDABILITY AND ACCESS

5.3.3 KEY TRADE AGREEMENTS AFFECTING TARIFFS

5.4 IMPACT OF HEALTHCARE TARIFFS ON PROVIDERS AND ANIMAL OWNERS

5.4.1 COST BURDEN ON FARMS, HOSPITALS, AND VETERINARY CLINICS

5.4.2 EFFECT ON PET OWNER AFFORDABILITY AND INSURANCE COVERAGE

5.4.3 TARIFFS AND THEIR ROLE IN VETERINARY TOURISM

5.5 TRADE AGREEMENTS AND HEALTHCARE TARIFFS

5.5.1 WTO REGULATIONS ON HEALTHCARE TARIFFS

5.5.2 IMPACT OF TRADE WARS ON SUPPLY CHAIN

5.5.3 WTO ROLE OF FREE TRADE AGREEMENTS IN REDUCING TARIFFS

5.6 IMPACT OF TARIFFS ON COSTS AND ACCESSIBILITY

5.7 IMPORTANCE OF TARIFFS IN THE SECTOR

6 REGULATORY FRAMEWORK

6.1 INTRODUCTION

6.2 REGULATORY APPROVAL PROCESS

6.3 GEOGRAPHIES’ EASE OF REGULATORY APPROVAL

6.4 REGULATORY APPROVAL PATHWAYS

6.5 LICENSING AND REGISTRATION

6.6 POST-MARKETING SURVEILLANCE

6.7 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES

6.8 CONCLUSION

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASING BURDEN OF VECTOR-BORNE PARASITES AFFECTING ANIMAL HEALTH.

7.1.2 RISING PET HUMANIZATION AND GROWING EXPENDITURE ON COMPANION ANIMAL WELLNESS.

7.1.3 INCREASING IMPORTANCE OF LIVESTOCK DISEASE MANAGEMENT FOR FOOD SUPPLY CHAIN STABILITY

7.1.4 INCREASING VETERINARY RECOMMENDATIONS FOR PREVENTIVE PARASITE CONTROL PRACTICES

7.2 RESTRAINTS

7.2.1 DEVELOPMENT OF PARASITE RESISTANCE AGAINST COMMONLY USED ACTIVE INGREDIENTS.

7.2.2 STRICT REGULATORY APPROVAL REQUIREMENTS FOR VETERINARY PHARMACEUTICAL PRODUCTS

7.3 OPPORTUNITIES

7.3.1 GROWTH IN DEMAND FOR NOVEL BIOLOGICAL AND LOW-CHEMICAL RESIDUE PARASITICIDE SOLUTIONS

7.3.2 EXPANSION OF ONLINE VETERINARY SERVICES AND DIGITAL ANIMAL HEALTHCARE PLATFORMS

7.3.3 DEVELOPMENT OF CUSTOMIZED PARASITE CONTROL SOLUTIONS BASED ON ANIMAL TYPE AND GEOGRAPHIC RISK

7.4 CHALLENGES

7.4.1 LIMITED VETERINARY INFRASTRUCTURE IN RURAL AND REMOTE FARMING COMMUNITIES

7.4.2 ENVIRONMENTAL IMPACT CONCERNS RELATED TO PARASITICIDE RESIDUES

8 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY PRODUCT

8.1 OVERVIEW

8.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)

8.2.1 ECTOPARASITICIDES

8.2.2 ENDOPARASITICIDES

8.2.3 ENDECTOCIDES

8.3 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)

8.3.1 ECTOPARASITICIDES

8.3.2 ENDOPARASITICIDES

8.3.3 ENDECTOCIDES

8.4 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNIT)

8.4.1 ECTOPARASITICIDES

8.4.2 ENDOPARASITICIDES

8.4.3 ENDECTOCIDES

8.5 NORTH AMERICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)

8.5.1 BY TYPE

8.5.2 BY DOSAGE FORM

8.5.3 BY ROUTE OF ADMINISTRATION

8.6 NORTH AMERICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.6.1 ORGANOPHOSPHATES

8.6.2 CARBAMATES

8.6.3 ORGANOCHLORINES

8.6.4 OTHERS

8.7 NORTH AMERICA ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.7.1 LINDANE

8.7.2 DIELDRIN

8.7.3 OTHERS

8.8 NORTH AMERICA CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.8.1 CARBARYL

8.8.2 METHOMYL

8.8.3 OTHERS

8.9 NORTH AMERICA ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.9.1 CHLORPYRIFOS

8.9.2 AZAMETHIPHOS

8.9.3 CHLORFENVINPHOS

8.9.4 OTHERS

8.1 NORTH AMERICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)

8.10.1 SOLUTION

8.10.2 TABLETS

8.10.3 SPRAYS

8.10.4 OTHERS

8.11 NORTH AMERICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)

8.11.1 TOPICAL

8.11.2 ORAL

8.11.3 OTHERS

8.12 NORTH AMERICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

8.12.1 NORTH AMERICA

8.12.2 EUROPE

8.12.3 ASIA-PACIFIC

8.12.4 SOUTH AMERICA

8.12.5 MIDDLE EAST & AFRICA

8.13 NORTH AMERICA ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)

8.13.1 BY TYPE

8.13.2 BY DOSAGE FORM

8.13.3 BY ROUTE OF ADMINISTRATION

8.14 NORTH AMERICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.14.1 BENZIMIDAZOLES

8.14.2 IMIDAZOTHIAZOLES

8.14.3 OTHERS

8.15 NORTH AMERICA BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.15.1 ALBENDAZOLE

8.15.2 FENBENDAZOLE

8.15.3 FEBANTEL

8.15.4 OTHERS

8.16 NORTH AMERICA IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.16.1 LEVAMISOLE

8.16.2 TETRAMISOLE

8.16.3 OTHERS

8.17 NORTH AMERICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)

8.17.1 SOLUTION

8.17.2 TABLETS

8.17.3 SPRAYS

8.17.4 OTHERS

8.18 NORTH AMERICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)

8.18.1 ORAL

8.18.2 INJECTABLES

8.18.3 TOPICAL

8.18.4 OTHERS

8.19 NORTH AMERICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

8.19.1 NORTH AMERICA

8.19.2 EUROPE

8.19.3 ASIA-PACIFIC

8.19.4 SOUTH AMERICA

8.19.5 MIDDLE EAST & AFRICA

8.2 NORTH AMERICA ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

8.20.1 ABAMECTIN

8.20.2 DORAMECTIN

8.20.3 OTHERS

8.21 NORTH AMERICA ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

8.21.1 NORTH AMERICA

8.21.2 EUROPE

8.21.3 ASIA-PACIFIC

8.21.4 SOUTH AMERICA

8.21.5 MIDDLE EAST & AFRICA

9 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DRUG CLASS

9.1 OVERVIEW

9.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)

9.2.1 ORGANOCHLORINES

9.2.2 ORGANOPHOSPHATES

9.2.3 CARBAMATES

9.2.4 BENZIMIDAZOLES

9.2.5 IMIDAZOTHIAZOLES

9.2.6 OTHERS

9.3 NORTH AMERICA ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

9.3.1 NORTH AMERICA

9.3.2 EUROPE

9.3.3 ASIA-PACIFIC

9.3.4 SOUTH AMERICA

9.3.5 MIDDLE EAST & AFRICA

9.4 NORTH AMERICA ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

9.4.1 NORTH AMERICA

9.4.2 EUROPE

9.4.3 ASIA-PACIFIC

9.4.4 SOUTH AMERICA

9.4.5 MIDDLE EAST & AFRICA

9.5 NORTH AMERICA CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

9.5.1 NORTH AMERICA

9.5.2 EUROPE

9.5.3 ASIA-PACIFIC

9.5.4 SOUTH AMERICA

9.5.5 MIDDLE EAST & AFRICA

9.6 NORTH AMERICA BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

9.6.1 NORTH AMERICA

9.6.2 EUROPE

9.6.3 ASIA-PACIFIC

9.6.4 SOUTH AMERICA

9.6.5 MIDDLE EAST & AFRICA

9.7 NORTH AMERICA IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

9.7.1 NORTH AMERICA

9.7.2 EUROPE

9.7.3 ASIA-PACIFIC

9.7.4 SOUTH AMERICA

9.7.5 MIDDLE EAST & AFRICA

9.8 NORTH AMERICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

9.8.1 NORTH AMERICA

9.8.2 EUROPE

9.8.3 ASIA-PACIFIC

9.8.4 SOUTH AMERICA

9.8.5 MIDDLE EAST & AFRICA

10 NORTH AMERICA ANIMAL PARASITICIDES MARKET , BY MODE OF PURCHASE

10.1 OVERVIEW

10.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)

10.2.1 PRESCRIPTION

10.2.2 OVER THE COUNTER (OTC)

10.3 NORTH AMERICA PRESCRIPTION IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

10.3.1 NORTH AMERICA

10.3.2 EUROPE

10.3.3 ASIA-PACIFIC

10.3.4 SOUTH AMERICA

10.3.5 MIDDLE EAST & AFRICA

10.4 NORTH AMERICA OVER THE COUNTER (OTC) IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

10.4.1 NORTH AMERICA

10.4.2 EUROPE

10.4.3 ASIA-PACIFIC

10.4.4 SOUTH AMERICA

10.4.5 MIDDLE EAST & AFRICA

11 NORTH AMERICA ANIMAL PARASITICIDES MARKET , BY DRUG TYPE

11.1 OVERVIEW

11.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)

11.2.1 BRANDED

11.2.2 GENERIC

11.3 NORTH AMERICA BRANDED IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

11.3.1 NORTH AMERICA

11.3.2 EUROPE

11.3.3 ASIA-PACIFIC

11.3.4 SOUTH AMERICA

11.3.5 MIDDLE EAST & AFRICA

11.4 NORTH AMERICA GENERIC IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

11.4.1 NORTH AMERICA

11.4.2 EUROPE

11.4.3 ASIA-PACIFIC

11.4.4 SOUTH AMERICA

11.4.5 MIDDLE EAST & AFRICA

12 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION

12.1 OVERVIEW

12.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)

12.2.1 TOPICAL

12.2.2 ORAL

12.2.3 INJECTABLES

12.2.4 OTHERS

12.3 NORTH AMERICA TOPICAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

12.3.1 NORTH AMERICA

12.3.2 EUROPE

12.3.3 ASIA-PACIFIC

12.3.4 SOUTH AMERICA

12.3.5 MIDDLE EAST & AFRICA

12.4 NORTH AMERICA ORAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

12.4.1 NORTH AMERICA

12.4.2 EUROPE

12.4.3 ASIA-PACIFIC

12.4.4 SOUTH AMERICA

12.4.5 MIDDLE EAST & AFRICA

12.5 NORTH AMERICA INJECTABLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

12.5.1 NORTH AMERICA

12.5.2 EUROPE

12.5.3 ASIA-PACIFIC

12.5.4 SOUTH AMERICA

12.5.5 MIDDLE EAST & AFRICA

12.6 NORTH AMERICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

12.6.1 NORTH AMERICA

12.6.2 EUROPE

12.6.3 ASIA-PACIFIC

12.6.4 SOUTH AMERICA

12.6.5 MIDDLE EAST & AFRICA

13 NORTH AMERICA ANIMAL PARASITICIDES MARKET , BY DOSAGE FORM

13.1 OVERVIEW

13.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)

13.2.1 SOLUTION

13.2.2 TABLETS

13.2.3 SPRAYS

13.2.4 OTHERS

13.3 NORTH AMERICA SOLUTION IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

13.3.1 NORTH AMERICA

13.3.2 EUROPE

13.3.3 ASIA-PACIFIC

13.3.4 SOUTH AMERICA

13.3.5 MIDDLE EAST & AFRICA

13.4 NORTH AMERICA TABLETS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

13.4.1 NORTH AMERICA

13.4.2 EUROPE

13.4.3 ASIA-PACIFIC

13.4.4 SOUTH AMERICA

13.4.5 MIDDLE EAST & AFRICA

13.5 NORTH AMERICA SPRAYS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

13.5.1 NORTH AMERICA

13.5.2 EUROPE

13.5.3 ASIA-PACIFIC

13.5.4 SOUTH AMERICA

13.5.5 MIDDLE EAST & AFRICA

13.6 NORTH AMERICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

13.6.1 NORTH AMERICA

13.6.2 EUROPE

13.6.3 ASIA-PACIFIC

13.6.4 SOUTH AMERICA

13.6.5 MIDDLE EAST & AFRICA

14 NORTH AMERICA ANIMAL PARASITICIDES MARKET , BY DISEASE TYPE

14.1 OVERVIEW

14.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE, 2018-2033 (USD THOUSAND)

14.2.1 FLEAS

14.2.2 TICKS

14.2.3 ROUND WORMS

14.2.4 HOOKWORMS

14.2.5 EAR MITES

14.2.6 OTHERS

14.3 NORTH AMERICA FLEAS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

14.3.1 NORTH AMERICA

14.3.2 EUROPE

14.3.3 ASIA-PACIFIC

14.3.4 SOUTH AMERICA

14.3.5 MIDDLE EAST & AFRICA

14.4 NORTH AMERICA TICKS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

14.4.1 NORTH AMERICA

14.4.2 EUROPE

14.4.3 ASIA-PACIFIC

14.4.4 SOUTH AMERICA

14.4.5 MIDDLE EAST & AFRICA

14.5 NORTH AMERICA ROUND WORMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

14.5.1 NORTH AMERICA

14.5.2 EUROPE

14.5.3 ASIA-PACIFIC

14.5.4 SOUTH AMERICA

14.5.5 MIDDLE EAST & AFRICA

14.6 NORTH AMERICA HOOKWORMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

14.6.1 NORTH AMERICA

14.6.2 EUROPE

14.6.3 ASIA-PACIFIC

14.6.4 SOUTH AMERICA

14.6.5 MIDDLE EAST & AFRICA

14.7 NORTH AMERICA EAR MITES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

14.7.1 NORTH AMERICA

14.7.2 EUROPE

14.7.3 ASIA-PACIFIC

14.7.4 SOUTH AMERICA

14.7.5 MIDDLE EAST & AFRICA

14.8 NORTH AMERICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

14.8.1 NORTH AMERICA

14.8.2 EUROPE

14.8.3 ASIA-PACIFIC

14.8.4 SOUTH AMERICA

14.8.5 MIDDLE EAST & AFRICA

15 NORTH AMERICA ANIMAL PARASITICIDES MARKET , BY ANIMAL TYPE

15.1 OVERVIEW

15.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)

15.2.1 COMPANION ANIMAL

15.2.2 FARM ANIMALS

15.3 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)

15.3.1 DOGS

15.3.2 CATS

15.3.3 HORSES

15.3.4 OTHER COMPANION ANIMALS

15.4 NORTH AMERICA COMPANION ANIMAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

15.4.1 NORTH AMERICA

15.4.2 EUROPE

15.4.3 ASIA-PACIFIC

15.4.4 SOUTH AMERICA

15.4.5 MIDDLE EAST & AFRICA

15.5 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)

15.5.1 CATTLE

15.5.2 SWINE

15.5.3 SHEEP AND GOATS

15.5.4 POULTRY

15.5.5 OTHER FARM ANIMALS

15.6 NORTH AMERICA FARM ANIMALS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

15.6.1 NORTH AMERICA

15.6.2 EUROPE

15.6.3 ASIA-PACIFIC

15.6.4 SOUTH AMERICA

15.6.5 MIDDLE EAST & AFRICA

16 NORTH AMERICA ANIMAL PARASITICIDES MARKET , BY END USER

16.1 OVERVIEW

16.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)

16.2.1 VETERINARY CLINICS

16.2.2 ANIMAL FARMS

16.2.3 HOME CARE

16.2.4 VETERINARY HOSPITALS

16.2.5 PET SHOPS

16.2.6 OTHERS

16.3 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)

16.3.1 VETERINARY CLINICS

16.3.2 ANIMAL FARMS

16.3.3 HOME CARE

16.3.4 VETERINARY HOSPITALS

16.3.5 PET SHOPS

16.3.6 OTHERS

16.4 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNIT)

16.4.1 VETERINARY CLINICS

16.4.2 ANIMAL FARMS

16.4.3 HOME CARE

16.4.4 VETERINARY HOSPITALS

16.4.5 PET SHOPS

16.4.6 OTHERS

16.5 NORTH AMERICA VETERINARY CLINICS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

16.5.1 NORTH AMERICA

16.5.2 EUROPE

16.5.3 ASIA-PACIFIC

16.5.4 SOUTH AMERICA

16.5.5 MIDDLE EAST & AFRICA

16.6 NORTH AMERICA ANIMAL FARMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

16.6.1 NORTH AMERICA

16.6.2 EUROPE

16.6.3 ASIA-PACIFIC

16.6.4 SOUTH AMERICA

16.6.5 MIDDLE EAST & AFRICA

16.7 NORTH AMERICA HOME CARE IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

16.7.1 NORTH AMERICA

16.7.2 EUROPE

16.7.3 ASIA-PACIFIC

16.7.4 SOUTH AMERICA

16.7.5 MIDDLE EAST & AFRICA

16.8 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)

16.8.1 PRIVATE

16.8.2 PUBLIC

16.9 NORTH AMERICA VETERINARY HOSPITALS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

16.9.1 NORTH AMERICA

16.9.2 EUROPE

16.9.3 ASIA-PACIFIC

16.9.4 SOUTH AMERICA

16.9.5 MIDDLE EAST & AFRICA

16.1 NORTH AMERICA PET SHOPS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

16.10.1 NORTH AMERICA

16.10.2 EUROPE

16.10.3 ASIA-PACIFIC

16.10.4 SOUTH AMERICA

16.10.5 MIDDLE EAST & AFRICA

16.11 NORTH AMERICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

16.11.1 NORTH AMERICA

16.11.2 EUROPE

16.11.3 ASIA-PACIFIC

16.11.4 SOUTH AMERICA

16.11.5 MIDDLE EAST & AFRICA

17 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL

17.1 OVERVIEW

17.2 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)

17.2.1 RETAIL SALES

17.2.2 DIRECT TENDER

17.2.3 OTHER

17.3 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)

17.3.1 RETAIL SALES

17.3.2 DIRECT TENDER

17.3.3 OTHER

17.4 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNIT)

17.4.1 RETAIL SALES

17.4.2 DIRECT TENDER

17.4.3 OTHER

17.5 NORTH AMERICA RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

17.5.1 OFFLINE SALES

17.5.2 ONLINE SALES

17.6 NORTH AMERICA RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

17.6.1 NORTH AMERICA

17.6.2 EUROPE

17.6.3 ASIA-PACIFIC

17.6.4 SOUTH AMERICA

17.6.5 MIDDLE EAST & AFRICA

17.7 NORTH AMERICA DIRECT TENDER IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

17.7.1 NORTH AMERICA

17.7.2 EUROPE

17.7.3 ASIA-PACIFIC

17.7.4 SOUTH AMERICA

17.7.5 MIDDLE EAST & AFRICA

17.8 NORTH AMERICA OTHER IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)

17.8.1 NORTH AMERICA

17.8.2 EUROPE

17.8.3 ASIA-PACIFIC

17.8.4 SOUTH AMERICA

17.8.5 MIDDLE EAST & AFRICA

18 NORTH AMERICA ANIMAL PARASITICIDES MARKET, BY REGION

18.1 NORTH AMERICA

18.1.1 U.S

18.1.2 CANADA

18.1.3 MEXICO

19 NORTH AMERICA ANIMAL PARASITICIDES MARKET COMPANY LANDSCAPE

19.1 COMPANY SHARE ANALYSIS: GLOBAL

20 SWOT ANALYSIS

21 COMPANY PROFILES

21.1 ZOETIS SERVICES LLC

21.1.1 COMPANY SNAPSHOT

21.1.2 REVENUE ANALYSIS

21.1.3 COMPANY SHARE ANALYSIS

21.1.4 PRODUCT PORTFOLIO

21.1.5 RECENT DEVELOPMENT

21.2 MERCK & CO., INC

21.2.1 COMPANY SNAPSHOT

21.2.2 REVENUE ANALYSIS

21.2.3 COMPANY SHARE ANALYSIS

21.2.4 PRODUCT PORTFOLIO

21.2.5 RECENT DEVELOPMENT

21.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH

21.3.1 COMPANY SNAPSHOT

21.3.2 COMPANY SHARE ANALYSIS

21.3.3 PRODUCT PORTFOLIO

21.3.4 RECENT DEVELOPMENT

21.4 ELANCO

21.4.1 COMPANY SNAPSHOT

21.4.2 REVENUE ANALYSIS

21.4.3 COMPANY SHARE ANALYSIS

21.4.4 PRODUCT PORTFOLIO

21.4.5 RECENT DEVELOPMENT

21.5 CEVA

21.5.1 COMPANY SNAPSHOT

21.5.2 COMPANY SHARE ANALYSIS

21.5.3 PRODUCT PORTFOLIO

21.5.4 RECENT DEVELOPMENT

21.6 AGROVET MARKET ANIMAL HEALTH

21.6.1 COMPANY SNAPSHOT

21.6.2 PRODUCT PORTFOLIO

21.6.3 RECENT DEVELOPMENT

21.7 BIMEDA, INC.

21.7.1 COMPANY SNAPSHOT

21.7.2 PRODUCT PORTFOLIO

21.7.3 RECENT DEVELOPMENT

21.8 BIOGÉNESIS BAGÓ

21.8.1 COMPANY SNAPSHOT

21.8.2 PRODUCT PORTFOLIO

21.8.3 RECENT DEVELOPMENT

21.9 BIOVETA, A.S

21.9.1 COMPANY SNAPSHOT

21.9.2 PRODUCT PORTFOLIO

21.9.3 RECENT DEVELOPMENT

21.1 CHANELLE PHARMA

21.10.1 COMPANY SNAPSHOT

21.10.2 PRODUCT PORTFOLIO

21.10.3 RECENT DEVELOPMENT/NEWS

21.11 DECHRA PHARMACEUTICALS

21.11.1 COMPANY SNAPSHOT

21.11.2 PRODUCT PORTFOLIO

21.11.3 RECENT DEVELOPMENT

21.12 FARMABASE

21.12.1 COMPANY SNAPSHOT

21.12.2 PRODUCT PORTFOLIO

21.12.3 RECENT DEVELOPMENT

21.13 HUVEPHARMA

21.13.1 COMPANY SNAPSHOT

21.13.2 PRODUCT PORTFOLIO

21.13.3 RECENT DEVELOPMENT

21.14 INMED ANIMAL HEALTH

21.14.1 COMPANY SNAPSHOT

21.14.2 PRODUCT PORTFOLIO

21.14.3 RECENT DEVELOPMENT/NEWS

21.15 KRKA, D. D., NOVO MESTO

21.15.1 COMPANY SNAPSHOT

21.15.2 REVENUE ANALYSIS

21.15.3 PRODUCT PORTFOLIO

21.15.4 RECENT DEVELOPMENT

21.16 KYORITSU SEIYAKU CORPORATION

21.16.1 COMPANY SNAPSHOT

21.16.2 PRODUCT PORTFOLIO

21.16.3 RECENT DEVELOPMENT

21.17 NORBROOK

21.17.1 COMPANY SNAPSHOT

21.17.2 PRODUCT PORTFOLIO

21.17.3 RECENT DEVELOPMENT

21.18 OUROFINO SAÚDE ANIMAL

21.18.1 COMPANY SNAPSHOT

21.18.2 REVENUE ANALYSIS

21.18.3 PRODUCT PORTFOLIO

21.18.4 RECENT DEVELOPMENT

21.19 ATCO HEALTHCARE PVT. LTD.

21.19.1 COMPANY SNAPSHOT

21.19.2 PRODUCT PORTFOLIO

21.19.3 RECENT DEVELOPMENT

21.2 PECUS HEALTHCARE PVT LTD

21.20.1 COMPANY SNAPSHOT

21.20.2 PRODUCT PORTFOLIO

21.20.3 RECENT DEVELOPMENT

21.21 PETIQ, LLC

21.21.1 COMPANY SNAPSHOT

21.21.2 PRODUCT PORTFOLIO

21.21.3 RECENT DEVELOPMENT

21.22 PHIBRO

21.22.1 COMPANY SNAPSHOT

21.22.2 PRODUCT PORTFOLIO

21.22.3 RECENT DEVELOPMENT/NEWS

21.23 PRODIVET PHARMACEUTICALS

21.23.1 COMPANY SNAPSHOT

21.23.2 PRODUCT PORTFOLIO

21.23.3 RECENT DEVELOPMENT

21.24 VETOQUINOL

21.24.1 COMPANY SNAPSHOT

21.24.2 REVENUE ANALYSIS

21.24.3 PRODUCT PORTFOLIO

21.24.4 RECENT DEVELOPMENT

21.25 VIRBAC.

21.25.1 COMPANY SNAPSHOT

21.25.2 REVENUE ANALYSIS

21.25.3 PRODUCT PORTFOLIO

21.25.4 RECENT DEVELOPMENT

21.26 VIYASH SCIENTIFIC LTD.

21.26.1 COMPANY SNAPSHOT

21.26.2 PRODUCT PORTFOLIO

21.26.3 RECENT DEVELOPMENT/NEWS

21.26.4 PRODUCT PORTFOLIO

21.26.5 RECENT DEVELOPMENT

22 QUESTIONNAIRE

23 RELATED REPORTS